For Its Blood Test to Detect Early-stage Prostate Cancer, Mumbai-based Datar Cancer Genetics Gets 'Breakthrough Designation' from the US FDA
Representational Image The US FDA grants the coveted Breakthrough Designation for Early-Stage Prost…
Representational Image The US FDA grants the coveted Breakthrough Designation for Early-Stage Prost…
BANGALORE, India, March 11, 2021 /PRNewswire/ -- 4baseCare, an Illumina Accelerator backed precisio…